مباشر

CellDeep-sea megafauna co-opts microbial energy metabolism genes to withstand ultra-long starvation CellReplaying germinal center evolution on a quantified affinity landscape CellXenophagocytosis blockade enhances interspecies chimerism FierceBiotechADA: Pfizer pads case for berobenatide in obesity, adding validation to Metsera buy Endpoints News#ADA26: Pfizer monthly shot shows effect on obesity, diabetes Endpoints News#ADA26: Roche to start Phase 2 petrelintide, enicepatide combo trial this year Endpoints NewsLawmakers propose China restrictions; #ASCO26 recap; and more FierceBiotech‘It looks like this hypothesis will pan out’: Cullinan unveils data building case for autoimmune TCEs Endpoints News#ADA26: Roche incretin shot works in mid-stage trial in type 1 diabetes Clinical OMICsBlood-Based Risk Score Could Enable Earlier Lung Cancer Prevention Clinical OMICsMicroglial State Shift May Determine Whether Alzheimer’s Disease Pathology Leads to Dementia Endpoints NewsIn Washington, biotech's China hawks are winning the conversation

Illumina ٢٠ يناير ٢٠٢٦

Illumina Gets Reimbursement For FDA-Approved TruSight Oncology Comprehensive Test, Stock Down - Nasdaq

Illumina Gets Reimbursement For FDA-Approved TruSight Oncology Comprehensive Test, Stock Down - Nasdaq

المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.